Completed
Therapeutic Effect of Crizotinib for Rearrangement-negative, High Phosphorylated ALK Patients
NCT05792644
- Conditions
- ALK Phosphorylation
- Locations
-
- Harbin Medical University Cancer Hospital Harbin, Heilongjiang, China